[HTML][HTML] The current status of thrombosis and anticoagulation therapy in patients with COVID-19 in Japan: From the CLOT-COVID study

Y Nishimoto, S Yachi, M Takeyama, I Tsujino… - Journal of …, 2022 - Elsevier
Background Data on thrombosis and current real-world management strategies for
anticoagulation therapy are scarce but important for understanding current issues and …

Tromboprofilaxis en COVID-19. Nuevas evidencias

R Ferrandis, P Sierra, A Gomez-Luque - Revista Española de …, 2023 - Elsevier
Recientes publicaciones han puesto en duda la eficacia de la utilización de dosis
terapéuticas o intermedias de heparina de bajo peso molecular (HBPM) en pacientes …

Systematic screening for a proximal DVT in COVID-19 hospitalized patients: results of a comparative study

Y Fares, YC Sinzogan-Eyoum, P Billoir… - JMV-Journal de …, 2021 - Elsevier
Introduction The COVID-19 pandemic is associated with a high incidence of venous
thromboembolism questioning the utility of a systematic screening for deep venous …

[HTML][HTML] Renal infarction associated with asymptomatic COVID-19 infection

NP Murray, C Fuentealba, E Reyes… - … , Transfusion and Cell …, 2021 - SciELO Brasil
Renal infarction is an infrequent condition resulting from obstruction of a renal artery. The
symptoms it causes are non-specific and as a result the diagnosis may be missed, resulting …

[HTML][HTML] The effect of corticosteroids, antibiotics, and anticoagulants on the development of post-COVID-19 syndrome in COVID-19 hospitalized patients 6 months after …

J Davelaar, N Jessurun, G Schaap, C Bode… - Clinical and …, 2023 - Springer
To assess the effect of pharmacotherapeutic interventions commonly employed in the
management of COVID-19 hospitalized patients on the development of post-COVID-19 …